A microplastics blood test is not the same thing as a personal health forecast.
The research is attention-grabbing, but daygauge keeps the product boundary clear: imported lab context only, not diagnosis or risk prediction.
Is there a blood test for microplastics?
A 2022 study reported plastic particles in human blood samples, but this does not establish a simple consumer interpretation for individual health decisions.
What the research signal is
A widely cited 2022 paper reported detection and quantification of plastic particles in human whole blood samples.
That is a research-context finding. It does not mean a lifestyle app can estimate a person's blood microplastics level.
The interpretation problem
Testing can be sensitive to collection, lab methods and contamination controls.
Even when a result is valid, translating it into individual advice requires expertise and more evidence than an app should pretend to have.
The daygauge boundary
daygauge can store imported lab results as private context, with source, date and confidence notes.
It should never infer DHT, hormones, fertility, disease risk or treatment actions from a microplastics result.
Sources daygauge can cite without overclaiming.
These sources inform product wording and evidence labels. They should not be turned into personal diagnosis, treatment or disease-risk prediction.
- Discovery and quantification of plastic particle pollution in human blood
- Environment International study page
- Microplastics and human health review
Research context only. daygauge does not diagnose, treat, prevent or predict disease risk. Personal medical concerns belong with a qualified clinician.
Related daygauge guides.
Want daygauge to explain this against your own baseline?
Join the TestFlight waitlist and tell us which pattern you want daygauge to explain first.
iOS TestFlight first · paid app, one plan · evidence context, not medical advice